Analysts: BioMed Realty Trust Inc (BMR.N)
BMR.N on New York Stock Exchange
20.47USD
2:13pm EDT
20.47USD
2:13pm EDT
Price Change (% chg)
$-0.19 (-0.92%)
$-0.19 (-0.92%)
Prev Close
$20.66
$20.66
Open
$20.70
$20.70
Day's High
$20.75
$20.75
Day's Low
$20.47
$20.47
Volume
121,530
121,530
Avg. Vol
513,293
513,293
52-wk High
$23.13
$23.13
52-wk Low
$18.20
$18.20
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.34 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 4 | 4 | 4 | 3 |
| (2) OUTPERFORM | 2 | 2 | 2 | 2 |
| (3) HOLD | 6 | 6 | 6 | 7 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.17 | 2.17 | 2.17 | 2.33 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 5 | 142.80 | 155.43 | 136.74 | 133.79 |
| Quarter Ending Dec-13 | 5 | 144.47 | 155.24 | 136.74 | 135.21 |
| Year Ending Dec-13 | 7 | 585.84 | 611.69 | 546.95 | 533.96 |
| Year Ending Dec-14 | 8 | 606.75 | 666.69 | 552.42 | 549.58 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 10 | 0.34 | 0.35 | 0.32 | 0.34 |
| Quarter Ending Dec-13 | 10 | 0.34 | 0.36 | 0.32 | 0.34 |
| Year Ending Dec-13 | 11 | 1.48 | 1.52 | 1.38 | 1.36 |
| Year Ending Dec-14 | 13 | 1.47 | 1.54 | 1.42 | 1.46 |
| LT Growth Rate (%) | 2 | 5.50 | 6.00 | 5.00 | 5.50 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 136.93 | 160.45 | 23.52 | 17.18 |
| Quarter Ending Dec-12 | 134.71 | 138.77 | 4.06 | 3.01 |
| Quarter Ending Sep-12 | 130.32 | 134.54 | 4.21 | 3.23 |
| Quarter Ending Jun-12 | 122.31 | 124.85 | 2.53 | 2.07 |
| Quarter Ending Mar-12 | 116.87 | 120.01 | 3.14 | 2.69 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.38 | 0.47 | 0.09 | 22.91 |
| Quarter Ending Dec-12 | 0.34 | 0.33 | 0.01 | 3.65 |
| Quarter Ending Sep-12 | 0.32 | 0.33 | 0.01 | 1.69 |
| Quarter Ending Jun-12 | 0.29 | 0.32 | 0.03 | 9.66 |
| Quarter Ending Mar-12 | 0.31 | 0.30 | 0.01 | 1.90 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 142.80 | 142.80 | 142.80 | 146.87 | 133.79 |
| Quarter Ending Dec-13 | 144.47 | 144.47 | 144.47 | 148.19 | 135.21 |
| Year Ending Dec-13 | 585.84 | 585.84 | 585.84 | 582.79 | 533.96 |
| Year Ending Dec-14 | 606.75 | 606.75 | 606.75 | 611.29 | 549.58 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 |
| Quarter Ending Dec-13 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 |
| Quarter Ending Dec-13 | 1.48 | 1.48 | 1.46 | 1.49 | 1.36 |
| Quarter Ending Dec-14 | 1.47 | 1.47 | 1.47 | 1.48 | 1.46 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 1 | 0 |
| Year Ending Dec-13 | 0 | 0 | 1 | 0 |
| Year Ending Dec-14 | 0 | 0 | 1 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ Factual Report
|
$127.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates